Ltd has entered into a memorandum of understanding with
Victoria-based Deakin University in Australia. Deakin
University is Australia''s fastest growing university in
multi-disciplinary research with a strong orientation
on biotechnology and biosciences research.
MoU includes establishing the Deakin Research Institute
in Bangalore; joint development of a mammalian cell bio-processing
facility at Geelong in Victoria, Australia.
through its metabolic research unit, Deakin will undertake
research on metabolic diseases on behalf of Biocon.
manage the high levels of innovation required in bio pharmaceuticals,
Biocon supplements its R&D efforts by working with
academic institutions and biotechnology companies around
tie-up with Deakin, which has a proven research capability
in a multi- disciplinary environment, will enable Biocon
to utilise this expertise in mammalian cell bio-processing
and metabolic diseases.
signing of this MOU will formally initiate collaboration
in research and education between Biocon and Deakin University,
Australia," said Kiran Mazumdar-Shaw, chairman and
managing director, Biocon. "This partnership will
provide valuable access to a world of medical knowledge
and scientific training, together with opportunities for
exchange of scientists to facilitate projects in areas
of mutual interest," she added.